Amber was selected to present her work entitled, “Integrative mass spectrometry, RNA-sequencing and ChIP-sequencing identifies DLK1 as an epigenetically regulated target in neuroblastoma,” as a talk at the 67th ASMS Conference on Mass Spectrometry and Allied Topics. The conference is an annual gathering for the American Society for Mass Spectrometry (ASMS) and was held this year in Atlanta, Georgia.